Researchers report activating cannabinoid signalling can increase activity in retinal ganglion cells.
While endocannabinoids have been reported to play a role in anti-inflammation in some areas of the brain, a new study reveals they may cause inflammation in the cerebellum.
Amyloid beta has been implicated in blocking endocannabinoids in the hippocampus; impairing learning and memory long before Alzheimer's plaques form in the brain.
Anandamide, an endogenous compound produced in the body, plays a role in reversing memories of traumatic events. The findings could lead to new treatments for PTSD.
Researchers have found a naturally occurring protein, know as diazepam binding inhibitor, secreted only in discrete areas of the brain may act as a Valium-like break in certain types of epilepsy.
Researchers discover the FABP5 protein is key to how endocannibinoids travel from neurons to receptors.
Receptor reacts to THC, as well as NAGly, a new study reports.
A new study finds THC reduces amyloid beta proteins in human neurons.
Cannabis consumption during pregnancy is associated with a slightly increased risk of a child developing psychosis at age ten. The findings also shed new light on the role endocannabinoids play in neurodevelopment.
Researchers report a new drug can help to reduce symptoms of cannabis withdrawal for those with cannabis use disorder.
Using optogenetics, researchers have identified a causal association between dopamine and avoidance behavior linked to pain and fear.
Researchers have discovered a lipid that may act as a 'switch' to increase or decrease the motivation to consume nicotine.
